Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001
-
Shares outstanding
-
53,041,500
-
Total 13F shares
-
31,376,638
-
Share change
-
+894,405
-
Total reported value
-
$3,977,739,304
-
Put/Call ratio
-
72%
-
Price per share
-
$126.93
-
Number of holders
-
187
-
Value change
-
+$124,455,773
-
Number of buys
-
95
-
Number of sells
-
111
Institutional Holders of Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) as of Q2 2021
As of 30 Jun 2021 Cardlytics, Inc. - Common Stock, par value $0.0001 (CDLX) had 187 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 31,376,638 shares of stock of the company.
Largest 10 holders included CAS Investment Partners, LLC, WELLINGTON MANAGEMENT GROUP LLP, VANGUARD GROUP INC, BlackRock Inc., JPMORGAN CHASE & CO, Alua Capital Management LP, KPS Global Asset Management UK Ltd, 683 Capital Management, LLC, MORGAN STANLEY, and Antipodean Advisors LLC.
This table shows 187 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.